Florian Lafaille

Characterization of a new anticancer agent, EAPB0203, and its main metabolites: nuclear magnetic resonance and liquid chromatography-mass spectrometry studies.

F. Bressolle, C. Enjalbal, B. Banaigs, 2012, Analytical chemistry.

Metabolism and Pharmacokinetics of EAPB0203 and EAPB0503, Two Imidazoquinoxaline Compounds Previously Shown to Have Antitumoral Activity on Melanoma and T-Lymphomas

F. Pinguet, F. Bressolle, J. Cooper, 2010, Drug Metabolism and Disposition.

Microsoft Word-16821466-file00

F. Pinguet, F. Bressolle, J. Cooper, 2010 .

Structural characterization of in vitro metabolites of the new anticancer agent EAPB0503 by liquid chromatography-tandem mass spectrometry.

F. Bressolle, C. Enjalbal, I. Solassol, 2014, Journal of pharmaceutical and biomedical analysis.

Characterization of a new anticancer agent, EAPB0203, and its main metabolites: nuclear magnetic resonance and liquid chromatography-mass spectrometry studies.

F. Bressolle, C. Enjalbal, B. Banaigs, 2012, Analytical chemistry.